Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

NCT03544736 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Nivolumab
RADIATION: Radiotherapy
DRUG: Chemotherapy
PROCEDURE: Surgery

Sponsor

Oslo University Hospital

Collaborators

[object Object]